Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: A bibliometric analysis of

Jiale Zhang1, Chenyang Ji2, Xu Zhai3

  • 1Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.

Insights

This bibliometric analysis maps the research landscape of anti-inflammatory treatments for coronary heart disease (CHD). It highlights key trends and emerging hotspots in CHD inflammation research, guiding future therapeutic development.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Bibliometrics

Background:

  • Coronary heart disease (CHD) involves arterial plaque formation driven by inflammation, not just lipid deposition.
  • Emerging clinical studies support anti-inflammatory therapies for CHD, but a comprehensive overview of research trends is lacking.
  • This study provides a visual bibliometric analysis of anti-inflammatory research in CHD.

Purpose of the Study:

  • To visually map and analyze the research landscape of anti-inflammatory interventions for coronary heart disease (CHD).
  • To identify current research hotspots, frontiers, and emerging trends in CHD and inflammation.
  • To provide a foundation for future research directions in anti-inflammatory therapies for CHD.

Main Methods:

  • Data sourced from the Web of Science Core Collection (WoSCC) database (1990-2022).
  • Analysis of publication years, countries, organizations, authors, and citations using WoSCC tools.
  • Visual bibliometric networks constructed using CiteSpace and VOSviewer to identify trends and hotspots.

Main Results:

  • 5,818 papers published, with a notable increase in publications since 2003.
  • The United States leads in publications, with Harvard University as the most prolific institution.
  • Key research areas include inflammation, C-reactive protein, CHD, nonsteroidal anti-inflammatory drugs, and myocardial infarction, with NLRP3 inflammasome as a recent burst topic.

Conclusions:

  • This bibliometric analysis offers a comprehensive perspective on anti-inflammatory research in CHD.
  • It identifies key players, influential publications, and evolving research themes.
  • The findings are significant for guiding future research and therapeutic strategies in managing CHD through anti-inflammatory approaches.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
27
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
40
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
19
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
575
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
42